---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-047980"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2024-11-27T23:59:59+00:00"
generated_at: "2026-05-29T13:30:48.919085+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Gyre Therapeutics enters $50M at-the-market equity offering with Jefferies

## Summary
- ATM agreement filed Nov 27, 2024; up to $50M of common stock may be sold.
- Jefferies LLC acts as sales agent; commission up to 3.0% of gross proceeds.
- Proceeds intended for R&D, manufacturing, scale-up, and general corporate purposes.
- Sales may be made on Nasdaq under effective S-3 shelf registration statement.

## SEC filing metadata
- accession: 0001140361-24-047980
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2024-11-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/0001140361-24-047980-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/ny20036484x4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-047980
- JSON: https://secwatch.observer/filing/0001140361-24-047980.json
- Plain text: https://secwatch.observer/filing/0001140361-24-047980.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.